Segantii Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-39,999	Closed	-$182K	–	122
2017 Q1	$182K	Buy	+39,999	New	+$182K	0.03%	153